medline.ch Respirationstrakt Neoplasie

	Ready, Set, Screen: Evaluating Community Readiness for Lung Cancer Screening Among Non-Hispanic Black Populations in Florida: Brief Report. JTO Clin Res Rep Monestime S, White A, Theodore R, Raez LE, Granville CA, Harris D, King JC. PMID: 41953891 [PubMed]
	Outcome and safety of SBRT in centrally and ultra-centrally located lung tumours: A PRISMA-based systematic review and Meta-Analysis. Clin Transl Radiat Oncol Wiegreffe S, Adebahr S, Schimek-Jasch T, Philipp Layer J, Dejonckheere CS, Sarria GR, Scafa D, Nour Y, Caglayan L, Baltas D, Moustakis C, Henrik Nicolay N, Rimner A, Grosu AL, Nestle U, Gkika E. PMID: 41953588 [PubMed]
	Prognostic impact of the lymph node yield on survival in patients with stage I lung adenocarcinoma receiving sublobar resection. Front Mol Biosci Li Y, Li J, Xu X, Ding Q, Chen Y, Mao Y. PMID: 41953047 [PubMed]
	Case report: Double-lung transplantation for Hermansky-Pudlak syndrome-associated pulmonary fibrosis and early-stage lung cancer. Front Immunol Li X, Ding L, Li B, Ding Z, Wang K, Li J, Gao X. PMID: 41953037 [PubMed - indexed for MEDLINE]
	Decoding Brain Metastasis With Liquid Biopsy: Biomarkers and Technologies in EGFR-Mutant NSCLC. Cancer Med Sun Y, Wang Q, Zhu P, Li Z, Liu T, Yin R. PMID: 41952341 [PubMed - indexed for MEDLINE]
	The Promise of Chemotherapy-Free Strategies in Advanced Driver-Negative NSCLC: A Systematic Review and Network Meta-Analysis of Antiangiogenic Combination Therapies. Cancer Med Li Z, Zhao W, Guo W, Lu X, Jia C, Ma J, Zhou Q, Yang X, Jiang J. PMID: 41952287 [PubMed - indexed for MEDLINE]
	Survival by Detection Pathway in Patients With Lung Cancer-A Nationwide Descriptive Epidemiological Study in Japan. Int J Cancer Koto R, Yamamoto A, Takashima I, Iwao C, Shin JH, Hayashi Y, Kitagawa H, Horie Y. PMID: 41952286 [PubMed - as supplied by publisher]
	Predicting lung cancer stage at diagnosis based on self-reported symptoms and background factors using machine learning models. Sci Rep Gustavell T, Sissala N, Pernemalm M, Baba, Eriksson LE. PMID: 41951730 [PubMed - as supplied by publisher]
	Corrigendum to "Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial": [Ann Oncol 36 (2025) 775-785]. Ann Oncol Felip E, Rojas CI, Schenker M, Kowalski DM, Casarini IA, Csöszi T, , Martins J, Calles Blanco A, Wang CC, Wang M, Ramirez Fallas RAL, Yoshioka H, Nair S, Song X, Deng X, Lala M, Eiras R, Takahashi T. PMID: 41951457 [PubMed - as supplied by publisher]
	Landscape of volatile organic compounds for differential diagnosis, pathological typing, and severity prediction in lung cancer: a large population-based prospective study. J Adv Res Xiang R, Hu P, Liu M, Dai W, Tian B, Li W, Liu X, Zhuang X, Yang X, Xie T, Hu B, He J, Ma K, Bie J, Shi Y, Liao J, Xie S, Yang X, Li J, Yang Y, Liao P, Xie T, Zhang Q, Luo H, Duan Y, Li Q. PMID: 41951045 [PubMed - as supplied by publisher]
	SKYSCRAPER-02C: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer in China. J Thorac Oncol Lu S, Fang J, Yu Y, Fan Y, Dong X, Wang Z, Wang Q, Wang J, Cui J, Pan H, Wu Q, Lin C, Zhang L, Meng R, Liu C, Huang X, Patil NS. PMID: 41950998 [PubMed - as supplied by publisher]
	Mapping the mutational terrain of lung adenocarcinoma: A Danish cohort study of 880 patients. Cancer Treat Res Commun Georgsen JB, Jakobsen MV, Meldgaard P, Lade-Keller J, Jepsen P, Nielsen PS, Dyrborg L, Steiniche T. PMID: 41950707 [PubMed - as supplied by publisher]
	Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026. Am Soc Clin Oncol Educ Book Bortolot M, Saw SPL, Pietroluongo E, Rajath G, Patel A, Garassino M, Remon J. PMID: 41950438 [PubMed - indexed for MEDLINE]
	Multimodal Assessment of Biological Age Following Radiation Therapy Among Patients With Early-Stage NSCLC. JAMA Netw Open Lee G, Haugg F, Bontempi D, He J, Bitterman DS, Pai S, Guthier C, Fitzgerald KJ, Kozono DE, Kann BH, Aerts HJWL, Mak RH. PMID: 41949867 [PubMed - indexed for MEDLINE]
	Cost-effectiveness of pembrolizumab plus chemotherapy for metastatic non-small cell lung cancer: a head-to-head trial vs. real-world comparison. J Med Econ Teppala S, Koo J, Clarke S, Lu CY. PMID: 41949826 [PubMed - indexed for MEDLINE]
	Incidental discovery of second primary lung tumors in breast cancer patients: An institutional case series. Oncologist Iancu A, Gwin W, Vinayak S, Linden H, Specht J, Symonds L, Davidson N, Hunter N. PMID: 41949764 [PubMed - as supplied by publisher]
	Applications and challenges of multi-omics approaches in lung cancer research and precision treatment. Front Genet Zhang S, Xu R, Zheng Q, Chen B, Li W. PMID: 41948518 [PubMed]
	Prognostic Implications of Programmed Cell Death Ligand 1 Expression, Cluster of Differentiation 8-Positive T-Cell Infiltration, and Related Immunophenotypes in Invasive Mucinous Adenocarcinoma of the Lung: A Multicenter Study. MedComm (2020) Zhang G, Zheng C, Jia J, Li X, Wang L, Zhang L, Zhang Y, Yue M, Zhang S, Liu Y, Xue L, Xue Q, He J. PMID: 41948454 [PubMed]
	CLIC6 and ANLN: novel exosome-related prognostic markers and therapeutic targets in lung adenocarcinoma. Front Immunol Miao Y, Li T, Li R, Liu Y. PMID: 41948338 [PubMed - indexed for MEDLINE]
	Radon and Non-Cancer Pulmonary Health Effects in Children: A State of The Art Review. Pediatr Pulmonol Banzon TM, Koutrakis P, Garshick E, Gaffin JM, Phipatanakul W. PMID: 41947778 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 158694

Seite 1 von 7935



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung